01—Abstract
Summary
Summary of the 10-K filed February 23, 2021. Cited figures are marked; the original filing is the authoritative source.
Aflac Incorporated reported total revenues of $22.1 billiona for the year ended December 31, 2020, a slight decrease from the previous year, primarily impacted by the global COVID-19 pandemic.
Despite revenue pressures, the company demonstrated resilience with net earnings of $4.8 billionb, a significant increase driven by a $1.4 billion benefit from the release of valuation allowances on deferred foreign tax credits due to new U.S. tax regulations. The company's core operations in Japan remain the primary driver of earnings, contributing approximately 68% of total revenues and 83% of total assets. Aflac Japan continues to be a leader in cancer and medical insurance, adapting to market trends and focusing on products less sensitive to interest rate fluctuations.
Aflac U.S. expanded its product offerings through acquisitions, including group life, disability, and absence management products, and is also enhancing its digital sales capabilities. Navigating the uncertainties of the pandemic, Aflac maintained a strong liquidity and capital position by issuing senior notes and managing its capital allocation tactically.
The company is committed to its solvency margin ratios and risk-based capital ratios, with contingency plans in place. While sales were impacted by the pandemic due to reduced face-to-face interactions, Aflac accelerated digital investments to support long-term productivity and customer service.
02—Key points
Key Highlights
- Total revenues of $22.1 billion in 2020, slightly down from $22.3 billion in 2019, impacted by COVID-19.
- Net earnings significantly increased to $4.8 billion in 2020, up from $3.3 billion in 2019, largely due to a $1.4 billion tax benefit related to deferred foreign tax credits.
- Aflac Japan remains the dominant segment, contributing 68% of revenues and 83% of assets, with continued leadership in cancer and medical insurance.
- Aflac U.S. grew its product portfolio through acquisitions, adding group life, disability, and absence management business.
- The company maintained a strong liquidity and capital position, issuing $1 billion in U.S. senior notes and ¥57 billion in Japanese senior notes in 2020 to support its financial resources.
- The company repurchased $1.5 billion (37.9 million shares) of its common stock in 2020.
- The dividend per share increased to $1.45 (declared) in 2020, with a further 17.9% increase announced for Q1 2021.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2020filed February 23, 2021Financial Statements
FY2020 against FY2019
| Line item | FY2020FY2019 | Change |
|---|---|---|
| Revenue | $22.15B$22.31B | −0.7% |
| SG&A Expenses | $3.42B$3.09B | +10.7% |
| Operating Expenses | $6.19B$5.92B | +4.6% |
| Operating Income | $4.42B$4.46B | −1.0% |
| Interest Expense | $242.00M$228.00M | +6.1% |
| Net Income | $4.78B$3.30B | +44.6% |
| EPS (Basic) | $6.69$4.45 | +50.3% |
| EPS (Diluted) | $6.67$4.43 | +50.6% |
| Shares Outstanding (Basic) | 713.70M742.41M | −3.9% |
| Shares Outstanding (Diluted) | 716.19M746.43M | −4.1% |
05—Questions
Frequently Asked Questions
How did the COVID-19 pandemic impact Aflac's financial performance in 2020?
The COVID-19 pandemic impacted Aflac's sales, leading to a decrease in new annualized premium sales in both Japan and the U.S. due to reduced face-to-face interactions. However, claims related to routine medical needs decreased, partially offsetting the impact. The company also accelerated digital investments to adapt to the changing environment and maintained strong liquidity and capital.
What is the significance of Aflac Japan to the company's overall performance?
Aflac Japan is the principal contributor to Aflac Incorporated's consolidated earnings. In 2020, it accounted for approximately 68% of total revenues and 83% of total assets. The segment is a market leader in cancer and medical insurance in Japan and focuses on products that are less sensitive to interest rate fluctuations.
How is Aflac managing its investment portfolio in the current market environment?
Aflac's investment strategy prioritizes disciplined asset-liability management while seeking long-term risk-adjusted returns. In 2020, the company continued its de-risking activities, reducing positions in portfolios deemed more vulnerable due to the pandemic. The portfolio is diversified, with a significant portion in fixed-maturity securities, and the company actively monitors credit quality and market conditions.
What is Aflac's approach to capital management and shareholder returns?
Aflac maintains a strong liquidity and capital position, with robust capital ratios in both Japan and the U.S. The company is committed to prudent capital allocation, including tactical share repurchases and maintaining strong dividend payments, which saw an increase in 2020 and an announced increase for Q1 2021. They aim to maintain specific solvency margin and risk-based capital ratios as part of their risk management framework.
06—Continue